Joseph (Joe) Vazzano joined Abeona as Chief Financial Officer in March 2022. Before joining Abeona, he served as Chief Financial Officer of Avenue Therapeutics, Inc. (Nasdaq: ATXI) from February 2019 to January 2022, and previously as Avenue's Vice President of Finance and Corporate Controller from August 2017, where he secured multiple equity financings and served in a leadership role on a complex, two-stage acquisition with future contingent value rights. Earlier he was Assistant Corporate Controller at Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) from October 2016 to July 2017, helping grow the finance and accounting department during the company's transition from a development-stage company to a fully integrated commercial organization.